NewTimeSpace News:By the close of trading on May 6, 2026, DELTON(01989.HK) saw a gain of 14.5% in its share price, closing at HKD 214.8. During the session, it reached an intraday high of HKD 222 and touched an intraday low of HKD 189.8.
NewTimeSpace News: By the close of trading on May 6, 2026, GIGADEVICE(03986.HK) saw a gain of 14.49% in its share price, closing at HKD 533.5. During the session, it reached an intraday high of HKD 555 and touched an intraday low of HKD 490.2.
NewTimeSpace News: By the close of trading on May 6, 2026, MONTAGE TECH(06809.HK) saw a gain of 16.78% in its share price, closing at HKD 321.6. During the session, it reached an intraday high of HKD 335 and touched an intraday low of HKD 291.
NewTimeSpace News: MIDEA GROUP(00300.HK) will spend CNY 50 million to repurchase 622.9 thousand shares on May 6, 2026.
NewTimeSpace News: SF HOLDING(06936.HK) will spend CNY 299.99 million to repurchase 8.08 million shares on May 6, 2026.
NewTimeSpace News,By the close of trading on May 6, 2026, MS GROUP HLDGS(01451.HK) saw a gain of 30.08% in its share price, closing at HKD 1.6. During the session, it reached an intraday high of HKD 2.35 and touched an intraday low of HKD 1.54.
NewTimeSpace News,By the close of trading on May 6, 2026, IMMUNOTECH-B(06978.HK) saw a loss of 13.21% in its share price, closing at HKD 0.92. During the session, it reached an intraday high of HKD 1.04 and touched an intraday low of HKD 0.91.
NewTimeSpace News: SSY Group Limited (02005.HK) announced that the Group has obtained drug production registration approvals from the National Medical Products Administration (NMPA) for three products. Among them, Fat-Soluble Vitamin Injection (Ⅰ) (10ml) is the first approved domestic enterprise, deemed to have passed the consistency evaluation, for intravenous nutritional supplementation in children and infants. Metformin Hydrochloride Tablets (0.5g and 0.25g) are used for the treatment of type 2 diabetes mellitus. Doxazosin Mesylate Extended-Release Tablets (4mg) are indicated for benign prostatic hyperplasia and hypertension.
NewTimeSpace News: SUNDART HLDGS (01568.HK) plans to issue up to 22 million shares by placement, with estimated net proceeds of HKD 14.2 million.
NewTimeSpace News: REACH NEW HLDGS (08471.HK) plans to issue up to 245.2 million shares by placement, with estimated net proceeds of HKD 4.7 million.
NewTimeSpace News,May 04, 2026, SINOHYTEC(02402.HK) released its Annual Report for the period ended December 31, 2025, Total Revenue stood at CNY 258.54 million, decreased by 29.49% YoY
NewTimeSpace News,May 05, 2026, BUD APAC(01876.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at USD 1.49 billion, increased by 2.19% YoY
NewTimeSpace News: Suzhou Raybow Biotech Co., Ltd. (06938.HK) announced that it has achieved the third key milestone in its R&D collaboration with Boehringer Ingelheim (BI) for developing innovative therapeutic solutions for liver diseases (including Metabolic Dysfunction-Associated Steatohepatitis, MASH). MASH is a severe and progressive fatty liver disease affecting over 200 million people worldwide.
NewTimeSpace News: Simcere Pharmaceutical Group Limited (02096.HK) announced that SIM0613 for Injection, a self-developed antibody-drug conjugate (ADC) targeting LRRC15, has obtained the Clinical Trial Approval Notice issued by the National Medical Products Administration (NMPA). A clinical trial for advanced solid tumors is planned to be launched. Previously, Simcere Zaiming, a subsidiary of the Group, has signed an exclusive license agreement with Ipsen, entitling it to receive a total payment of up to USD 1.06 billion.
NewTimeSpace News: Yidu Tech Inc. (02158.HK) announced that its subsidiary, EVYD Research Private Limited, has recently won the bid for the implementation, support, and maintenance of the DR BUDDY project for Singapore Health Services Pte Ltd. The total project value is approximately SGD 2,277,996. This project serves as a key milestone for the company's expansion into the Singapore market.
NewTimeSpace News：EV DYNAMICS (00476.HK) plans to issue in total 3.84 million shares by subscription, with estimated net proceeds of HKD 1.98 million.
